Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurobiol Aging. 2014 Nov;35(11):2617-24. doi: 10.1016/j.neurobiolaging.2014.05.001. Epub 2014 May 9.

Seizure resistance without parkinsonism in aged mice after tau reduction.

Author information

1
Center for Neurodegeneration and Experimental Therapeutics, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.
2
Southern Research Institute, Birmingham, AL, USA.
3
Center for Neurodegeneration and Experimental Therapeutics, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: eroberson@uab.edu.

Abstract

Tau is an emerging target for Alzheimer's disease (AD) and other conditions with epileptiform activity. Genetic tau reduction (in Tau(+/-) and Tau(-/-) mice) prevents deficits in AD models and has an excitoprotective effect, increasing resistance to seizures, without causing apparent neuronal dysfunction. However, most studies of tau reduction have been conducted in <1-year-old mice, and the effects of tau reduction in aged mice are less clear. Specifically, whether the excitoprotective effects of tau reduction persist with aging is unknown and whether tau reduction causes neuronal dysfunction, including parkinsonism, with aging is controversial. Here, we performed a comprehensive analysis of 2-year-old Tau(+/+), Tau(+/-), and Tau(-/-) mice. In aged mice, tau reduction still conferred resistance to pentylenetetrazole-induced seizures. Moreover, tau reduction did not cause parkinsonian abnormalities in dopamine levels or motor function and did not cause iron accumulation or impaired cognition, although Tau(-/-) mice had mild hyperactivity and decreased brain weight. Importantly, the excitoprotective effect in aged Tau(+/-) mice was not accompanied by detectable abnormalities, indicating that partially reducing tau or blocking its function may be a safe and effective therapeutic approach for AD and other conditions with increased excitability.

KEYWORDS:

Alzheimer's disease; Epilepsy; Excitability; Microtubule; Parkinsonism; Seizure; Tau

[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center